Ozempic, Mounjaro, and Wegovy have received a lot of attention both in the media and the medical community over the past couple of years. This class of medications, known as GLP-1 receptor agonists, was initially developed for the treatment of Type 2 diabetes; however, their benefits for weight loss has resulted in a sharp increase in popularity in recent months. Because of this, we are seeing higher numbers of women taking these drugs during their reproductive years. You might be wondering about GLP-1 agonist use yourself and how that pertains to TTC (trying to conceive) either now or in the near future. Let’s take a look at what we know.